ArticleAntimicrobial agents and chemotherapy2015

Effects of raltegravir or elvitegravir resistance signature mutations on the barrier to dolutegravir resistance in vitro.

Takahiro Seki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.